{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cannabis sativa", "abuse", "cannabinoid receptors", "cannabinoids", "endocannabinoids", "hemp", "marijuana", "therapeutics", "toxicity", "\u0394-9-tetrahydrocannabinol (THC)"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33562446", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "30"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "02", "Day": "05"}], "Language": ["eng"], "ELocationID": ["117", "10.3390/toxins13020117"], "Journal": {"ISSN": "2072-6651", "JournalIssue": {"Volume": "13", "Issue": "2", "PubDate": {"Year": "2021", "Month": "Feb", "Day": "05"}}, "Title": "Toxins", "ISOAbbreviation": "Toxins (Basel)"}, "ArticleTitle": "Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.", "Abstract": {"AbstractText": ["For thousands of years, <i>Cannabis sativa</i> has been utilized as a medicine and for recreational and spiritual purposes. Phytocannabinoids are a family of compounds that are found in the cannabis plant, which is known for its psychotogenic and euphoric effects; the main psychotropic constituent of cannabis is \u03949-tetrahydrocannabinol (\u03949-THC). The pharmacological effects of cannabinoids are a result of interactions between those compounds and cannabinoid receptors, CB1 and CB2, located in many parts of the human body. Cannabis is used as a therapeutic agent for treating pain and emesis. Some cannabinoids are clinically applied for treating chronic pain, particularly cancer and multiple sclerosis-associated pain, for appetite stimulation and anti-emesis in HIV/AIDS and cancer patients, and for spasticity treatment in multiple sclerosis and epilepsy patients. Medical cannabis varies from recreational cannabis in the chemical content of THC and cannabidiol (CBD), modes of administration, and safety. Despite the therapeutic effects of cannabis, exposure to high concentrations of THC, the main compound that is responsible for most of the intoxicating effects experienced by users, could lead to psychological events and adverse effects that affect almost all body systems, such as neurological (dizziness, drowsiness, seizures, coma, and others), ophthalmological (mydriasis and conjunctival hyperemia), cardiovascular (tachycardia and arterial hypertension), and gastrointestinal (nausea, vomiting, and thirst), mainly associated with recreational use. Cannabis toxicity in children is more concerning and can cause serious adverse effects such as acute neurological symptoms (stupor), lethargy, seizures, and even coma. More countries are legalizing the commercial production and sale of cannabis for medicinal use, and some for recreational use as well. Liberalization of cannabis laws has led to increased incidence of toxicity, hyperemesis syndrome, lung disease cardiovascular disease, reduced fertility, tolerance, and dependence with chronic prolonged use. This review focuses on the potential therapeutic effects of cannabis and cannabinoids, as well as the acute and chronic toxic effects of cannabis use on various body systems."]}, "AuthorList": [{"Identifier": ["0000-0003-1233-7826"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Department, Faculty of Pharmacy, Al-Quds University, Jerusalem Abu Dis P144, Palestine."}], "LastName": "Breijyeh", "ForeName": "Zeinab", "Initials": "Z"}, {"Identifier": ["0000-0003-3171-2679"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Department, Faculty of Pharmacy, Al-Quds University, Jerusalem Abu Dis P144, Palestine."}], "LastName": "Jubeh", "ForeName": "Buthaina", "Initials": "B"}, {"Identifier": ["0000-0002-0857-2367"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Sciences, University of Basilicata, 85100 Potenza, Italy."}, {"Identifier": [], "Affiliation": "Department of Geography, Environmental Management & Energy Studies, University of Johannesburg, Johannesburg 2092, South Africa."}], "LastName": "Bufo", "ForeName": "Sabino A", "Initials": "SA"}, {"Identifier": ["0000-0001-5526-4490"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Department, Faculty of Pharmacy, Al-Quds University, Jerusalem Abu Dis P144, Palestine."}, {"Identifier": [], "Affiliation": "Department of Sciences, University of Basilicata, 85100 Potenza, Italy."}], "LastName": "Karaman", "ForeName": "Rafik", "Initials": "R"}, {"Identifier": ["0000-0002-3716-2666"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of European Cultures (DICEM), University of Basilicata, 75100 Matera, Italy."}], "LastName": "Scrano", "ForeName": "Laura", "Initials": "L"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Toxins (Basel)", "NlmUniqueID": "101530765", "ISSNLinking": "2072-6651"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cannabinoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Medical Marijuana"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Cannabinoid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["adverse effects", "isolation & purification", "therapeutic use"], "DescriptorName": "Cannabinoids"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Cannabis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "physiopathology", "psychology"], "DescriptorName": "Marijuana Abuse"}, {"QualifierName": ["adverse effects", "therapeutic use"], "DescriptorName": "Medical Marijuana"}, {"QualifierName": ["drug effects", "metabolism", "physiopathology"], "DescriptorName": "Nervous System"}, {"QualifierName": ["metabolism", "physiopathology", "psychology"], "DescriptorName": "Neurotoxicity Syndromes"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Receptors, Cannabinoid"}, {"QualifierName": [], "DescriptorName": "Signal Transduction"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Bonini S.A., Premoli M., Tambaro S., Kumar A., Maccarinelli G., Memo M., Mastinu A. Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. J. Ethnopharmacol. 2018;227:300\u2013315. doi: 10.1016/j.jep.2018.09.004.", "ArticleIdList": ["10.1016/j.jep.2018.09.004", "30205181"]}, {"Citation": "Meissner H., Cascella M. Cannabidiol (CBD) StatPearls; Treasure Island, FL, USA: 2020.", "ArticleIdList": ["32310508"]}, {"Citation": "Gon\u00e7alves J., Rosado T., Soares S., Sim\u00e3o A.Y., Caramelo D., Lu\u00eds \u00c2., Fern\u00e1ndez N., Barroso M., Gallardo E., Duarte A.P. Cannabis and Its Secondary Metabolites: Their Use as Therapeutic Drugs, Toxicological Aspects, and Analytical Determination. Medicines. 2019;6:31. doi: 10.3390/medicines6010031.", "ArticleIdList": ["10.3390/medicines6010031", "PMC6473697", "30813390"]}, {"Citation": "McPartland J.M. Cannabis Systematics at the Levels of Family, Genus, and Species. Cannabis Cannabinoid Res. 2018;3:203\u2013212. doi: 10.1089/can.2018.0039.", "ArticleIdList": ["10.1089/can.2018.0039", "PMC6225593", "30426073"]}, {"Citation": "National Academies of Sciences, Engineering, and Medicine . The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. The National Academies Press; Washington, DC, USA: 2017. p. 486.", "ArticleIdList": ["10.17226/24625", "28182367"]}, {"Citation": "Sharma P., Murthy P., Bharath M.S. Chemistry, metabolism, and toxicology of cannabis: Clinical implications. Iran. J. Psychiatry. 2012;7:149.", "ArticleIdList": ["PMC3570572", "23408483"]}, {"Citation": "Hazekamp A., Grotenhermen F. Review on clinical studies with cannabis and cannabinoids 2005\u20132009. Cannabinoids. 2010;5:1\u201321."}, {"Citation": "Russell C., Rueda S., Room R., Tyndall M., Fischer B. Routes of administration for cannabis use\u2014Basic prevalence and related health outcomes: A scoping review and synthesis. Int. J. Drug Policy. 2018;52:87\u201396. doi: 10.1016/j.drugpo.2017.11.008.", "ArticleIdList": ["10.1016/j.drugpo.2017.11.008", "29277082"]}, {"Citation": "Barrus D.G., Capogrossi K.L., Cates S.C., Gourdet C.K., Peiper N.C., Novak S.P., Lefever T.W., Wiley J.L. Tasty THC: Promises and Challenges of Cannabis Edibles. Methods Rep. 2016;2016 doi: 10.3768/rtipress.2016.op.0035.1611.", "ArticleIdList": ["10.3768/rtipress.2016.op.0035.1611", "PMC5260817", "28127591"]}, {"Citation": "ElSohly M.A., Radwan M.M., Gul W., Chandra S., Galal A. Phytocannabinoids. Springer; Berlin/Heidelberg, Germany: 2017. Phytochemistry of Cannabis sativa L. pp. 1\u201336.", "ArticleIdList": ["28120229"]}, {"Citation": "Solymosi K., K\u00f6falvi A. Cannabis: A treasure trove or pandora\u2019s box? Mini Rev. Med. Chem. 2017;17:1223\u20131291. doi: 10.2174/1389557516666161004162133.", "ArticleIdList": ["10.2174/1389557516666161004162133", "27719666"]}, {"Citation": "Turner S.E., Williams C.M., Iversen L., Whalley B.J. Phytocannabinoids. Springer; Berlin/Heidelberg, Germany: 2017. Molecular pharmacology of phytocannabinoids; pp. 61\u2013101.", "ArticleIdList": ["28120231"]}, {"Citation": "Andre C.M., Hausman J.-F., Guerriero G. Cannabis sativa: The plant of the thousand and one molecules. Front. Plant Sci. 2016;7:19. doi: 10.3389/fpls.2016.00019.", "ArticleIdList": ["10.3389/fpls.2016.00019", "PMC4740396", "26870049"]}, {"Citation": "Russo E.B. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br. J. Pharmacol. 2011;163:1344\u20131364. doi: 10.1111/j.1476-5381.2011.01238.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01238.x", "PMC3165946", "21749363"]}, {"Citation": "Champagne A.S., McFaull S.R., Thompson W., Bang F. Surveillance from the high ground: Sentinel surveillance of injuries and poisonings associated with cannabis. Health Promot. Chronic Dis. Prev. Can. Res. Policy Pract. 2020;40:184\u2013192. doi: 10.24095/hpcdp.40.5/6.07.", "ArticleIdList": ["10.24095/hpcdp.40.5/6.07", "PMC7367429", "32529978"]}, {"Citation": "Colizzi M., Ruggeri M., Bhattacharyya S. Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition. Front. Psychol. 2020;11:833. doi: 10.3389/fpsyg.2020.00833.", "ArticleIdList": ["10.3389/fpsyg.2020.00833", "PMC7247841", "32528345"]}, {"Citation": "Zhang M.W., Ho R.C. The Cannabis Dilemma: A Review of Its Associated Risks and Clinical Efficacy. J. Addict. 2015;2015:707596. doi: 10.1155/2015/707596.", "ArticleIdList": ["10.1155/2015/707596", "PMC4619948", "26539302"]}, {"Citation": "Drugs O.O. World Drug Report 2014. United Nations Development Programm; New York, NY, USA: 2014. Crime."}, {"Citation": "Pratt M., Stevens A., Thuku M., Butler C., Skidmore B., Wieland L.S., Clemons M., Kanji S., Hutton B. Benefits and harms of medical cannabis: A scoping review of systematic reviews. Syst. Rev. 2019;8:320. doi: 10.1186/s13643-019-1243-x.", "ArticleIdList": ["10.1186/s13643-019-1243-x", "PMC6905063", "31823819"]}, {"Citation": "Memedovich K.A., Dowsett L.E., Spackman E., Noseworthy T., Clement F. The adverse health effects and harms related to marijuana use: An overview review. CMAJ Open. 2018;6:E339\u2013E346. doi: 10.9778/cmajo.20180023.", "ArticleIdList": ["10.9778/cmajo.20180023", "PMC6182105", "30115639"]}, {"Citation": "ElSohly M.A., Radwan M.M., Gul W., Chandra S., Galal A. Phytochemistry of Cannabis sativa L. Prog. Chem. Org. Nat. Prod. 2017;103:1\u201336. doi: 10.1007/978-3-319-45541-9_1.", "ArticleIdList": ["10.1007/978-3-319-45541-9_1", "28120229"]}, {"Citation": "Citti C., Linciano P., Russo F., Luongo L., Iannotta M., Maione S., Lagana A., Capriotti A.L., Forni F., Vandelli M.A., et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Delta(9)-tetrahydrocannabinol: Delta(9)-Tetrahydrocannabiphorol. Sci. Rep. 2019;9:20335. doi: 10.1038/s41598-019-56785-1.", "ArticleIdList": ["10.1038/s41598-019-56785-1", "PMC6937300", "31889124"]}, {"Citation": "Fischedick J.T. Identification of Terpenoid Chemotypes Among High (-)-trans-Delta(9)- Tetrahydrocannabinol-Producing Cannabis sativa L. Cultivars. Cannabis Cannabinoid Res. 2017;2:34\u201347. doi: 10.1089/can.2016.0040.", "ArticleIdList": ["10.1089/can.2016.0040", "PMC5436332", "28861503"]}, {"Citation": "ElSohly M.A., Mehmedic Z., Foster S., Gon C., Chandra S., Church J.C. Changes in Cannabis Potency Over the Last 2 Decades (1995\u20132014): Analysis of Current Data in the United States. Biol. Psychiatry. 2016;79:613\u2013619. doi: 10.1016/j.biopsych.2016.01.004.", "ArticleIdList": ["10.1016/j.biopsych.2016.01.004", "PMC4987131", "26903403"]}, {"Citation": "VanDolah H.J., Bauer B.A., Mauck K.F. Clinicians\u2019 Guide to Cannabidiol and Hemp Oils. Mayo Clin. Proc. 2019;94:1840\u20131851. doi: 10.1016/j.mayocp.2019.01.003.", "ArticleIdList": ["10.1016/j.mayocp.2019.01.003", "31447137"]}, {"Citation": "Lu H.C., Mackie K. An Introduction to the Endogenous Cannabinoid System. Biol. Psychiatry. 2016;79:516\u2013525. doi: 10.1016/j.biopsych.2015.07.028.", "ArticleIdList": ["10.1016/j.biopsych.2015.07.028", "PMC4789136", "26698193"]}, {"Citation": "Almogi-Hazan O., Or R. Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back. Int. J. Mol. Sci. 2020;21:4448. doi: 10.3390/ijms21124448.", "ArticleIdList": ["10.3390/ijms21124448", "PMC7352399", "32585801"]}, {"Citation": "Elphick M.R. The evolution and comparative neurobiology of endocannabinoid signalling. Philos. Trans. R. Soc. B Biol. Sci. 2012;367:3201\u20133215. doi: 10.1098/rstb.2011.0394.", "ArticleIdList": ["10.1098/rstb.2011.0394", "PMC3481536", "23108540"]}, {"Citation": "Pertwee R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin. Br. J. Pharmacol. 2008;153:199\u2013215. doi: 10.1038/sj.bjp.0707442.", "ArticleIdList": ["10.1038/sj.bjp.0707442", "PMC2219532", "17828291"]}, {"Citation": "Fern\u00e1ndez-Ruiz J., Sagredo O., Pazos M.R., Garc\u00eda C., Pertwee R., Mechoulam R., Mart\u00ednez-Orgado J. Cannabidiol for neurodegenerative disorders: Important new clinical applications for this phytocannabinoid? Br. J. Clin. Pharmacol. 2013;75:323\u2013333. doi: 10.1111/j.1365-2125.2012.04341.x.", "ArticleIdList": ["10.1111/j.1365-2125.2012.04341.x", "PMC3579248", "22625422"]}, {"Citation": "An D., Peigneur S., Hendrickx L.A., Tytgat J. Targeting Cannabinoid Receptors: Current Status and Prospects of Natural Products. Int. J. Mol. Sci. 2020;21 doi: 10.3390/ijms21145064.", "ArticleIdList": ["10.3390/ijms21145064", "PMC7404216", "32709050"]}, {"Citation": "Pertwee R.G. The pharmacology of cannabinoid receptors and their ligands: An overview. Int. J. Obes. 2006;30(Suppl. 1):S13\u2013S18. doi: 10.1038/sj.ijo.0803272.", "ArticleIdList": ["10.1038/sj.ijo.0803272", "16570099"]}, {"Citation": "Howlett A.C., Abood M.E. CB1 and CB2 Receptor Pharmacology. Adv. Pharmacol. 2017;80:169\u2013206. doi: 10.1016/bs.apha.2017.03.007.", "ArticleIdList": ["10.1016/bs.apha.2017.03.007", "PMC5812699", "28826534"]}, {"Citation": "Console-Bram L., Marcu J., Abood M.E. Cannabinoid receptors: Nomenclature and pharmacological principles. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2012;38:4\u201315. doi: 10.1016/j.pnpbp.2012.02.009.", "ArticleIdList": ["10.1016/j.pnpbp.2012.02.009", "PMC3378782", "22421596"]}, {"Citation": "Hillard C.J., Manna S., Greenberg M.J., DiCamelli R., Ross R.A., Stevenson L.A., Murphy V., Pertwee R.G., Campbell W.B. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1) J. Pharmacol. Exp. Ther. 1999;289:1427\u20131433.", "ArticleIdList": ["10336536"]}, {"Citation": "Price M.R., Baillie G.L., Thomas A., Stevenson L.A., Easson M., Goodwin R., McLean A., McIntosh L., Goodwin G., Walker G., et al. Allosteric modulation of the cannabinoid CB1 receptor. Mol. Pharmacol. 2005;68:1484\u20131495. doi: 10.1124/mol.105.016162.", "ArticleIdList": ["10.1124/mol.105.016162", "16113085"]}, {"Citation": "Morales P., Goya P., Jagerovic N., Hernandez-Folgado L. Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review. Cannabis Cannabinoid Res. 2016;1:22\u201330. doi: 10.1089/can.2015.0005.", "ArticleIdList": ["10.1089/can.2015.0005", "PMC5576597", "28861476"]}, {"Citation": "Gado F., Di Cesare Mannelli L., Lucarini E., Bertini S., Cappelli E., Digiacomo M., Stevenson L.A., Macchia M., Tuccinardi T., Ghelardini C., et al. Identification of the First Synthetic Allosteric Modulator of the CB2 Receptors and Evidence of Its Efficacy for Neuropathic Pain Relief. J. Med. Chem. 2019;62:276\u2013287. doi: 10.1021/acs.jmedchem.8b00368.", "ArticleIdList": ["10.1021/acs.jmedchem.8b00368", "29990428"]}, {"Citation": "Tham M., Yilmaz O., Alaverdashvili M., Kelly M.E.M., Denovan-Wright E.M., Laprairie R.B. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Br. J. Pharmacol. 2019;176:1455\u20131469. doi: 10.1111/bph.14440.", "ArticleIdList": ["10.1111/bph.14440", "PMC6487556", "29981240"]}, {"Citation": "Staton P.C., Hatcher J.P., Walker D.J., Morrison A.D., Shapland E.M., Hughes J.P., Chong E., Mander P.K., Green P.J., Billinton A. The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain. Pain. 2008;139:225\u2013236. doi: 10.1016/j.pain.2008.04.006.", "ArticleIdList": ["10.1016/j.pain.2008.04.006", "18502582"]}, {"Citation": "Huang S.M., Bisogno T., Petros T.J., Chang S.Y., Zavitsanos P.A., Zipkin R.E., Sivakumar R., Coop A., Maeda D.Y., De Petrocellis L. Identification of a new class of molecules, the arachidonyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem. 2001;276:42639\u201342644. doi: 10.1074/jbc.M107351200.", "ArticleIdList": ["10.1074/jbc.M107351200", "11518719"]}, {"Citation": "Laezza C., Pagano C., Navarra G., Pastorino O., Proto M.C., Fiore D., Piscopo C., Gazzerro P., Bifulco M. The Endocannabinoid System: A Target for Cancer Treatment. Int. J. Mol. Sci. 2020;21:747. doi: 10.3390/ijms21030747.", "ArticleIdList": ["10.3390/ijms21030747", "PMC7037210", "31979368"]}, {"Citation": "Russo E.B., Burnett A., Hall B., Parker K.K. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem. Res. 2005;30:1037\u20131043. doi: 10.1007/s11064-005-6978-1.", "ArticleIdList": ["10.1007/s11064-005-6978-1", "16258853"]}, {"Citation": "Scavone J., Sterling R., Van Bockstaele E. Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal. Neuroscience. 2013;248:637\u2013654. doi: 10.1016/j.neuroscience.2013.04.034.", "ArticleIdList": ["10.1016/j.neuroscience.2013.04.034", "PMC3742578", "23624062"]}, {"Citation": "Fattore L., Fratta W. Beyond THC: The New Generation of Cannabinoid Designer Drugs. Front. Behav. Neurosci. 2011;5:60. doi: 10.3389/fnbeh.2011.00060.", "ArticleIdList": ["10.3389/fnbeh.2011.00060", "PMC3187647", "22007163"]}, {"Citation": "Cohen K., Weinstein A.M. Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective. Front. Public Health. 2018;6:162. doi: 10.3389/fpubh.2018.00162.", "ArticleIdList": ["10.3389/fpubh.2018.00162", "PMC5999798", "29930934"]}, {"Citation": "Sheikh N.K., Dua A. Cannabinoids. StatPearls; Treasure Island, FL, USA: 2020."}, {"Citation": "MacCallum C.A., Russo E.B. Practical considerations in medical cannabis administration and dosing. Eur. J. Intern. Med. 2018;49:12\u201319. doi: 10.1016/j.ejim.2018.01.004.", "ArticleIdList": ["10.1016/j.ejim.2018.01.004", "29307505"]}, {"Citation": "Hall W., Stjepanovi\u0107 D., Caulkins J., Lynskey M., Leung J., Campbell G., Degenhardt L. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Lancet. 2019;394:1580\u20131590. doi: 10.1016/S0140-6736(19)31789-1.", "ArticleIdList": ["10.1016/S0140-6736(19)31789-1", "31657733"]}, {"Citation": "Russo E.B. Cannabinoids in the management of difficult to treat pain. Ther. Clin. Risk Manag. 2008;4:245\u2013259. doi: 10.2147/TCRM.S1928.", "ArticleIdList": ["10.2147/TCRM.S1928", "PMC2503660", "18728714"]}, {"Citation": "Elikkottil J., Gupta P., Gupta K. The analgesic potential of cannabinoids. J. Opioid Manag. 2009;5:341\u2013357. doi: 10.5055/jom.2009.0034.", "ArticleIdList": ["10.5055/jom.2009.0034", "PMC3728280", "20073408"]}, {"Citation": "Boehnke K.F., Litinas E., Clauw D.J. Medical Cannabis Use Is Associated With Decreased Opiate Medication Use in a Retrospective Cross-Sectional Survey of Patients With Chronic Pain. J. Pain Off. J. Am. Pain Soc. 2016;17:739\u2013744. doi: 10.1016/j.jpain.2016.03.002.", "ArticleIdList": ["10.1016/j.jpain.2016.03.002", "27001005"]}, {"Citation": "Philpot L.M., Ebbert J.O., Hurt R.T. A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers. BMC Fam. Pract. 2019;20:17. doi: 10.1186/s12875-019-0906-y.", "ArticleIdList": ["10.1186/s12875-019-0906-y", "PMC6341534", "30669979"]}, {"Citation": "Reiman A., Welty M., Solomon P. Cannabis as a Substitute for Opioid-Based Pain Medication: Patient Self-Report. Cannabis Cannabinoid Res. 2017;2:160\u2013166. doi: 10.1089/can.2017.0012.", "ArticleIdList": ["10.1089/can.2017.0012", "PMC5569620", "28861516"]}, {"Citation": "Sexton M., Cuttler C., Finnell J.S., Mischley L.K. A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy. Cannabis Cannabinoid Res. 2016;1:131\u2013138. doi: 10.1089/can.2016.0007.", "ArticleIdList": ["10.1089/can.2016.0007", "PMC5549439", "28861489"]}, {"Citation": "Whiting P.F., Wolff R.F., Deshpande S., Di Nisio M., Duffy S., Hernandez A.V., Keurentjes J.C., Lang S., Misso K., Ryder S., et al. Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. JAMA. 2015;313:2456\u20132473. doi: 10.1001/jama.2015.6358.", "ArticleIdList": ["10.1001/jama.2015.6358", "26103030"]}, {"Citation": "Campbell G., Hall W.D., Peacock A., Lintzeris N., Bruno R., Larance B., Nielsen S., Cohen M., Chan G., Mattick R.P., et al. Effect of cannabis use in people with chronic non-cancer pain prescribed opioids: Findings from a 4-year prospective cohort study. Lancet Public Health. 2018;3:e341\u2013e350. doi: 10.1016/S2468-2667(18)30110-5.", "ArticleIdList": ["10.1016/S2468-2667(18)30110-5", "PMC6684473", "29976328"]}, {"Citation": "Hill K.P., Palastro M.D., Johnson B., Ditre J.W. Cannabis and Pain: A Clinical Review. Cannabis Cannabinoid Res. 2017;2:96\u2013104. doi: 10.1089/can.2017.0017.", "ArticleIdList": ["10.1089/can.2017.0017", "PMC5549367", "28861509"]}, {"Citation": "Russo E.B., Hohmann A.G. Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches. Springer; New York, NY, USA: 2013. Role of Cannabinoids in Pain Management; pp. 181\u2013197.", "ArticleIdList": ["10.1007/978-1-4614-1560-2_18"]}, {"Citation": "Randall M.D. Endocannabinoids and the haematological system. Br. J. Pharmacol. 2007;152:671\u2013675. doi: 10.1038/sj.bjp.0707420.", "ArticleIdList": ["10.1038/sj.bjp.0707420", "PMC2190025", "17704826"]}, {"Citation": "Lochte B.C., Beletsky A., Samuel N.K., Grant I. The Use of Cannabis for Headache Disorders. Cannabis Cannabinoid Res. 2017;2:61\u201371. doi: 10.1089/can.2016.0033.", "ArticleIdList": ["10.1089/can.2016.0033", "PMC5436334", "28861505"]}, {"Citation": "Bloomfield M.A., Ashok A.H., Volkow N.D., Howes O.D. The effects of Delta(9)-tetrahydrocannabinol on the dopamine system. Nature. 2016;539:369\u2013377. doi: 10.1038/nature20153.", "ArticleIdList": ["10.1038/nature20153", "PMC5123717", "27853201"]}, {"Citation": "Hoffman A.F., Oz M., Yang R., Lichtman A.H., Lupica C.R. Opposing actions of chronic Delta9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn. Mem. 2007;14:63\u201374. doi: 10.1101/lm.439007.", "ArticleIdList": ["10.1101/lm.439007", "PMC1828281", "17202425"]}, {"Citation": "Muller C., Morales P., Reggio P.H. Cannabinoid Ligands Targeting TRP Channels. Front. Mol. Neurosci. 2018;11:487. doi: 10.3389/fnmol.2018.00487.", "ArticleIdList": ["10.3389/fnmol.2018.00487", "PMC6340993", "30697147"]}, {"Citation": "Atalay S., Jarocka-Karpowicz I., Skrzydlewska E. Antioxidative and Anti-Inflammatory Properties of Cannabidiol. Antioxidants. 2019;9:21. doi: 10.3390/antiox9010021.", "ArticleIdList": ["10.3390/antiox9010021", "PMC7023045", "31881765"]}, {"Citation": "Han K.H., Lim S., Ryu J., Lee C.W., Kim Y., Kang J.H., Kang S.S., Ahn Y.K., Park C.S., Kim J.J. CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages. Cardiovasc. Res. 2009;84:378\u2013386. doi: 10.1093/cvr/cvp240.", "ArticleIdList": ["10.1093/cvr/cvp240", "19596672"]}, {"Citation": "Jean-Gilles L., Braitch M., Latif M.L., Aram J., Fahey A.J., Edwards L.J., Robins R.A., Tanasescu R., Tighe P.J., Gran B., et al. Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells. Acta Physiol. 2015;214:63\u201374. doi: 10.1111/apha.12474.", "ArticleIdList": ["10.1111/apha.12474", "PMC4669958", "25704169"]}, {"Citation": "Nichols J.M., Kaplan B.L.F. Immune responses regulated by cannabidiol. Cannabis Cannabinoid Res. 2020;5:12\u201331. doi: 10.1089/can.2018.0073.", "ArticleIdList": ["10.1089/can.2018.0073", "PMC7173676", "32322673"]}, {"Citation": "O\u2019Donnell B., Gupta V. Dronabinol. StatPearls; Treasure Island, FL, USA: 2020."}, {"Citation": "Bruni N., Della Pepa C., Oliaro-Bosso S., Pessione E., Gastaldi D., Dosio F. Cannabinoid Delivery Systems for Pain and Inflammation Treatment. Molecules. 2018;23:2478. doi: 10.3390/molecules23102478.", "ArticleIdList": ["10.3390/molecules23102478", "PMC6222489", "30262735"]}, {"Citation": "Burstein S.H., Zurier R.B. Cannabinoids, endocannabinoids, and related analogs in inflammation. AAPS J. 2009;11:109\u2013119. doi: 10.1208/s12248-009-9084-5.", "ArticleIdList": ["10.1208/s12248-009-9084-5", "PMC2664885", "19199042"]}, {"Citation": "Pertwee R.G. Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists. Curr. Med. Chem. 2010;17:1360\u20131381. doi: 10.2174/092986710790980050.", "ArticleIdList": ["10.2174/092986710790980050", "PMC3013229", "20166927"]}, {"Citation": "Vuckovic S., Srebro D., Vujovic K.S., Vucetic C., Prostran M. Cannabinoids and Pain: New Insights From Old Molecules. Front. Pharmacol. 2018;9:1259. doi: 10.3389/fphar.2018.01259.", "ArticleIdList": ["10.3389/fphar.2018.01259", "PMC6277878", "30542280"]}, {"Citation": "Tsang C.C., Giudice M.G. Nabilone for the Management of Pain. Pharmacotherapy. 2016;36:273\u2013286. doi: 10.1002/phar.1709.", "ArticleIdList": ["10.1002/phar.1709", "26923810"]}, {"Citation": "McGolrick D., Frey N. Nabilone for Chronic Pain Management: A Review of Clinical Effectiveness and Guidelines\u2014An Update. Canadian Agency for Drugs and Technologies in Health; Ottawa, ON, Canada: 2018.", "ArticleIdList": ["30896900"]}, {"Citation": "Burstein S.H. Ajulemic acid: Potential treatment for chronic inflammation. Pharmacol. Res. Perspect. 2018;6:e00394. doi: 10.1002/prp2.394.", "ArticleIdList": ["10.1002/prp2.394", "PMC5891661", "29638269"]}, {"Citation": "Zurier R.B., Sun Y.P., George K.L., Stebulis J.A., Rossetti R.G., Skulas A., Judge E., Serhan C.N. Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2009;23:1503\u20131509. doi: 10.1096/fj.08-118323.", "ArticleIdList": ["10.1096/fj.08-118323", "PMC2669421", "19124557"]}, {"Citation": "Burstein S. Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials. AAPS J. 2005;7:E143\u2013E148. doi: 10.1208/aapsj070115.", "ArticleIdList": ["10.1208/aapsj070115", "PMC2751505", "16146336"]}, {"Citation": "Giacoppo S., Bramanti P., Mazzon E. Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation. Mult. Scler. Relat. Disord. 2017;17:22\u201331. doi: 10.1016/j.msard.2017.06.015.", "ArticleIdList": ["10.1016/j.msard.2017.06.015", "29055461"]}, {"Citation": "Costa B., Colleoni M., Conti S., Trovato A.E., Bianchi M., Sotgiu M.L., Giagnoni G. Repeated treatment with the synthetic cannabinoid WIN 55,212-2 reduces both hyperalgesia and production of pronociceptive mediators in a rat model of neuropathic pain. Br. J. Pharmacol. 2004;141:4\u20138. doi: 10.1038/sj.bjp.0705587.", "ArticleIdList": ["10.1038/sj.bjp.0705587", "PMC1574173", "14662732"]}, {"Citation": "Hama A., Sagen J. Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain. J. Rehabil. Res. Dev. 2009;46:135\u2013143. doi: 10.1682/JRRD.2008.04.0049.", "ArticleIdList": ["10.1682/JRRD.2008.04.0049", "PMC2743245", "19533526"]}, {"Citation": "Guindon J., Hohmann A.G. Cannabinoid CB2 receptors: A therapeutic target for the treatment of inflammatory and neuropathic pain. Br. J. Pharmacol. 2008;153:319\u2013334. doi: 10.1038/sj.bjp.0707531.", "ArticleIdList": ["10.1038/sj.bjp.0707531", "PMC2219541", "17994113"]}, {"Citation": "Mao Y., Huang Y., Zhang Y., Wang C., Wu H., Tian X., Liu Y., Hou B., Liang Y., Rong H., et al. Cannabinoid receptor 2selective agonist JWH015 attenuates bone cancer pain through the amelioration of impaired autophagy flux induced by inflammatory mediators in the spinal cord. Mol. Med. Rep. 2019;20:5100\u20135110. doi: 10.3892/mmr.2019.10772.", "ArticleIdList": ["10.3892/mmr.2019.10772", "PMC6854597", "31661120"]}, {"Citation": "Li A.L., Carey L.M., Mackie K., Hohmann A.G. Cannabinoid CB2 Agonist GW405833 Suppresses Inflammatory and Neuropathic Pain through a CB1 Mechanism that is Independent of CB2 Receptors in Mice. J. Pharmacol. Exp. Ther. 2017;362:296\u2013305. doi: 10.1124/jpet.117.241901.", "ArticleIdList": ["10.1124/jpet.117.241901", "PMC5502377", "28592614"]}, {"Citation": "Sharkey K.A., Darmani N.A., Parker L.A. Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system. Eur. J. Pharmacol. 2014;722:134\u2013146. doi: 10.1016/j.ejphar.2013.09.068.", "ArticleIdList": ["10.1016/j.ejphar.2013.09.068", "PMC3883513", "24184696"]}, {"Citation": "Torii Y., Saito H., Matsuki N. Selective blockade of cytotoxic drug-induced emesis by 5-HT3 receptor antagonists in Suncus murinus. Jpn. J. Pharmacol. 1991;55:107\u2013113. doi: 10.1016/S0021-5198(19)39983-4.", "ArticleIdList": ["10.1016/S0021-5198(19)39983-4", "2041220"]}, {"Citation": "Parker L.A., Rock E.M., Limebeer C.L. Regulation of nausea and vomiting by cannabinoids. Br. J. Pharmacol. 2011;163:1411\u20131422. doi: 10.1111/j.1476-5381.2010.01176.x.", "ArticleIdList": ["10.1111/j.1476-5381.2010.01176.x", "PMC3165951", "21175589"]}, {"Citation": "Taylor B.N., Sauls R.S. Cannaboinoid Antiemetic Therapy. StatPearls; Treasure Island, FL, USA: 2020.", "ArticleIdList": ["30571051"]}, {"Citation": "Fraguas-Sanchez A.I., Torres-Suarez A.I. Medical Use of Cannabinoids. Drugs. 2018;78:1665\u20131703. doi: 10.1007/s40265-018-0996-1.", "ArticleIdList": ["10.1007/s40265-018-0996-1", "30374797"]}, {"Citation": "Brierley D.I., Samuels J., Duncan M., Whalley B.J., Williams C.M. Cannabigerol is a novel, well-tolerated appetite stimulant in pre-satiated rats. Psychopharmacology. 2016;233:3603\u20133613. doi: 10.1007/s00213-016-4397-4.", "ArticleIdList": ["10.1007/s00213-016-4397-4", "PMC5021742", "27503475"]}, {"Citation": "Kirkham T.C. Endocannabinoids in the regulation of appetite and body weight. Behav. Pharmacol. 2005;16:297\u2013313. doi: 10.1097/00008877-200509000-00004.", "ArticleIdList": ["10.1097/00008877-200509000-00004", "16148436"]}, {"Citation": "Beal J.E., Olson R., Laubenstein L., Morales J.O., Bellman P., Yangco B., Lefkowitz L., Plasse T.F., Shepard K.V. Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. J. Pain Symptom Manag. 1995;10:89\u201397. doi: 10.1016/0885-3924(94)00117-4.", "ArticleIdList": ["10.1016/0885-3924(94)00117-4", "7730690"]}, {"Citation": "Struwe M., Kaempfer S.H., Geiger C.J., Pavia A.T., Plasse T.F., Shepard K.V., Ries K., Evans T.G. Effect of dronabinol on nutritional status in HIV infection. Ann. Pharmacother. 1993;27:827\u2013831. doi: 10.1177/106002809302700701.", "ArticleIdList": ["10.1177/106002809302700701", "8395916"]}, {"Citation": "Abrams D.I. Integrating cannabis into clinical cancer care. Curr. Oncol. 2016;23:S8\u2013S14. doi: 10.3747/co.23.3099.", "ArticleIdList": ["10.3747/co.23.3099", "PMC4791148", "27022315"]}, {"Citation": "Ingram G., Pearson O.R. Cannabis and multiple sclerosis. Pract. Neurol. 2019;19:310\u2013315. doi: 10.1136/practneurol-2018-002137.", "ArticleIdList": ["10.1136/practneurol-2018-002137", "31201234"]}, {"Citation": "Rudroff T., Honce J.M. Cannabis and Multiple Sclerosis-The Way Forward. Front. Neurol. 2017;8:299. doi: 10.3389/fneur.2017.00299.", "ArticleIdList": ["10.3389/fneur.2017.00299", "PMC5481305", "28690588"]}, {"Citation": "Daris B., Tancer Verboten M., Knez Z., Ferk P. Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosn. J. Basic Med Sci. 2019;19:14\u201323. doi: 10.17305/bjbms.2018.3532.", "ArticleIdList": ["10.17305/bjbms.2018.3532", "PMC6387667", "30172249"]}, {"Citation": "Velasco G., Sanchez C., Guzman M. Anticancer mechanisms of cannabinoids. Curr. Oncol. 2016;23:S23\u2013S32. doi: 10.3747/co.23.3080.", "ArticleIdList": ["10.3747/co.23.3080", "PMC4791144", "27022311"]}, {"Citation": "Wang D., Wang H., Ning W., Backlund M.G., Dey S.K., DuBois R.N. Loss of cannabinoid receptor 1 accelerates intestinal tumor growth. Cancer Res. 2008;68:6468\u20136476. doi: 10.1158/0008-5472.CAN-08-0896.", "ArticleIdList": ["10.1158/0008-5472.CAN-08-0896", "PMC2561258", "18676872"]}, {"Citation": "Pertwee R.G., Howlett A.C., Abood M.E., Alexander S.P., Di Marzo V., Elphick M.R., Greasley P.J., Hansen H.S., Kunos G., Mackie K., et al. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: Beyond CB(1) and CB(2) Pharmacol. Rev. 2010;62:588\u2013631. doi: 10.1124/pr.110.003004.", "ArticleIdList": ["10.1124/pr.110.003004", "PMC2993256", "21079038"]}, {"Citation": "Borrelli F., Pagano E., Romano B., Panzera S., Maiello F., Coppola D., De Petrocellis L., Buono L., Orlando P., Izzo A.A. Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid. Carcinogenesis. 2014;35:2787\u20132797. doi: 10.1093/carcin/bgu205.", "ArticleIdList": ["10.1093/carcin/bgu205", "25269802"]}, {"Citation": "Yuan M., Kiertscher S.M., Cheng Q., Zoumalan R., Tashkin D.P., Roth M.D. Delta 9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J. Neuroimmunol. 2002;133:124\u2013131. doi: 10.1016/S0165-5728(02)00370-3.", "ArticleIdList": ["10.1016/S0165-5728(02)00370-3", "12446015"]}, {"Citation": "Blazquez C., Gonzalez-Feria L., Alvarez L., Haro A., Casanova M.L., Guzman M. Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res. 2004;64:5617\u20135623. doi: 10.1158/0008-5472.CAN-03-3927.", "ArticleIdList": ["10.1158/0008-5472.CAN-03-3927", "15313899"]}, {"Citation": "Sledzinski P., Zeyland J., Slomski R., Nowak A. The current state and future perspectives of cannabinoids in cancer biology. Cancer Med. 2018;7:765\u2013775. doi: 10.1002/cam4.1312.", "ArticleIdList": ["10.1002/cam4.1312", "PMC5852356", "29473338"]}, {"Citation": "Boros C., Parsons D., Zoanetti G., Ketteridge D., Kennedy D. Cannabis cookies: A cause of coma. J. Paediatr. Child Health. 1996;32:194\u2013195. doi: 10.1111/j.1440-1754.1996.tb00922.x.", "ArticleIdList": ["10.1111/j.1440-1754.1996.tb00922.x", "9156535"]}, {"Citation": "Macnab A., Anderson E., Susak L. Ingestion of cannabis: A cause of coma in children. Pediatric Emerg. Care. 1989;5:238\u2013239. doi: 10.1097/00006565-198912000-00010.", "ArticleIdList": ["10.1097/00006565-198912000-00010", "2602198"]}, {"Citation": "Richards J.R., Smith N.E., Moulin A.K. Unintentional cannabis ingestion in children: A systematic review. J. Pediatrics. 2017;190:142\u2013152. doi: 10.1016/j.jpeds.2017.07.005.", "ArticleIdList": ["10.1016/j.jpeds.2017.07.005", "28888560"]}, {"Citation": "Malik K., Kommana S., Paul J., Krakauer M. Synthetic cannabinoid induced ocular self-injury. Orbit. 2020:1\u20133. doi: 10.1080/01676830.2020.1781199.", "ArticleIdList": ["10.1080/01676830.2020.1781199", "32552411"]}, {"Citation": "Blazquez C., Ruiz-Calvo A., Bajo-Graneras R., Baufreton J.M., Resel E., Varilh M., Pagano Zottola A.C., Mariani Y., Cannich A., Rodriguez-Navarro J.A., et al. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination. eLife. 2020;9:e56811. doi: 10.7554/eLife.56811.", "ArticleIdList": ["10.7554/eLife.56811", "PMC7417168", "32773031"]}, {"Citation": "Gebremedhin D., Lange A.R., Campbell W.B., Hillard C.J., Harder D.R. Cannabinoid CB1 receptor of cat cerebral arterial muscle functions to inhibit L-type Ca2+ channel current. Am. J. Physiol. Heart Circ. Physiol. 1999;276:H2085\u2013H2093. doi: 10.1152/ajpheart.1999.276.6.H2085.", "ArticleIdList": ["10.1152/ajpheart.1999.276.6.H2085", "10362691"]}, {"Citation": "Grigg J., Manning V., Arunogiri S., Lubman D.I. Synthetic cannabinoid use disorder: An update for general psychiatrists. Australas. Psychiatry Bull. R. Aust. N. Z. Coll. Psychiatr. 2019;27:279\u2013283. doi: 10.1177/1039856218822749.", "ArticleIdList": ["10.1177/1039856218822749", "30663326"]}, {"Citation": "Hall W., Degenhardt L., Lynskey M. The Health and Psychological Effects of Cannabis Use. 2nd ed. Commonwealth of Australia; Canberra, Australia: 2001. (Monograph Series No. 44)."}, {"Citation": "van Amsterdam J., Brunt T., van den Brink W. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. J. Psychopharmacol. 2015;29:254\u2013263. doi: 10.1177/0269881114565142.", "ArticleIdList": ["10.1177/0269881114565142", "25586398"]}, {"Citation": "Ware M.A., Adams H., Guy G.W. The medicinal use of cannabis in the UK: Results of a nationwide survey. Int. J. Clin. Pract. 2005;59:291\u2013295. doi: 10.1111/j.1742-1241.2004.00271.x.", "ArticleIdList": ["10.1111/j.1742-1241.2004.00271.x", "15857325"]}, {"Citation": "Sullivan E., Austriaco N. A virtue analysis of recreational marijuana use. Linacre Q. 2016;83:158\u2013173. doi: 10.1080/00243639.2015.1125083.", "ArticleIdList": ["10.1080/00243639.2015.1125083", "PMC5102207", "27833195"]}, {"Citation": "Bostwick J.M. Blurred boundaries: The therapeutics and politics of medical marijuana. Mayo Clin. Proc. 2012;87:172\u2013186. doi: 10.1016/j.mayocp.2011.10.003.", "ArticleIdList": ["10.1016/j.mayocp.2011.10.003", "PMC3538401", "22305029"]}, {"Citation": "Turner A.R., Spurling B.C., Agrawal S. Marijuana Toxicity. StatPearls; Treasure Island, FL, USA: 2020.", "ArticleIdList": ["28613573"]}, {"Citation": "Rosenkrantz H., Heyman I.A., Braude M.C. Inhalation, parenteral and oral LD50 values of \u03949-tetrahydrocannabinol in Fischer rats. Toxicol. Appl. Pharmacol. 1974;28:18\u201327. doi: 10.1016/0041-008X(74)90126-4.", "ArticleIdList": ["10.1016/0041-008X(74)90126-4", "4852457"]}, {"Citation": "Ruiz C.M., Torrens A., Castillo E., Perrone C.R., Cevallos J., Inshishian V.C., Harder E.V., Justeson D.N., Huestis M.A., Swarup V., et al. Pharmacokinetic, behavioral, and brain activity effects of Delta(9)-tetrahydrocannabinol in adolescent male and female rats. Neuropsychopharmacology. 2020 doi: 10.1038/s41386-020-00839-w.", "ArticleIdList": ["10.1038/s41386-020-00839-w", "PMC8115040", "32927465"]}, {"Citation": "Cosker E., Schwitzer T., Ramoz N., Ligier F., Lalanne L., Gorwood P., Schwan R., Laprevote V. The effect of interactions between genetics and cannabis use on neurocognition. A review. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2018;82:95\u2013106. doi: 10.1016/j.pnpbp.2017.11.024.", "ArticleIdList": ["10.1016/j.pnpbp.2017.11.024", "29191570"]}, {"Citation": "Cooper Z.D., Haney M. Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug Alcohol Depend. 2014;136:85\u201391. doi: 10.1016/j.drugalcdep.2013.12.013.", "ArticleIdList": ["10.1016/j.drugalcdep.2013.12.013", "PMC4518446", "24440051"]}, {"Citation": "Weinberg D., Lande A., Hilton N., Kerns D.L. Intoxication from accidental marijuana ingestion. Pediatrics. 1983;71:848\u2013850.", "ArticleIdList": ["6300748"]}, {"Citation": "Boadu O., Gombolay G.Y., Caviness V.S., El Saleeby C.M. Intoxication From Accidental Marijuana Ingestion in Pediatric Patients: What May Lie Ahead. Pediatric Emerg. Care. 2020;36:e349\u2013e354. doi: 10.1097/PEC.0000000000001420.", "ArticleIdList": ["10.1097/PEC.0000000000001420", "29406477"]}, {"Citation": "Chinello M., Scommegna S., Shardlow A., Mazzoli F., De Giovanni N., Fucci N., Borgiani P., Ciccacci C., Locasciulli A., Calvani M. Cannabinoid poisoning by hemp seed oil in a child. Pediatric Emerg. Care. 2017;33:344\u2013345. doi: 10.1097/PEC.0000000000000780.", "ArticleIdList": ["10.1097/PEC.0000000000000780", "27299295"]}, {"Citation": "Carstairs S.D., Fujinaka M.K., Keeney G.E., Ly B.T. Prolonged coma in a child due to hashish ingestion with quantitation of THC metabolites in urine. J. Emerg. Med. 2011;41:e69\u2013e71. doi: 10.1016/j.jemermed.2010.05.032.", "ArticleIdList": ["10.1016/j.jemermed.2010.05.032", "20634020"]}, {"Citation": "Ware M.A., Wang T., Shapiro S., Collet J.-P., Boulanger A., Esdaile J.M., Gordon A., Lynch M., Moulin D.E., O\u2019Connell C. Cannabis for the management of pain: Assessment of safety study (COMPASS) J. Pain. 2015;16:1233\u20131242. doi: 10.1016/j.jpain.2015.07.014.", "ArticleIdList": ["10.1016/j.jpain.2015.07.014", "26385201"]}, {"Citation": "Wang T., Collet J.-P., Shapiro S., Ware M.A. Adverse effects of medical cannabinoids: A systematic review. CMAJ. 2008;178:1669\u20131678. doi: 10.1503/cmaj.071178.", "ArticleIdList": ["10.1503/cmaj.071178", "PMC2413308", "18559804"]}, {"Citation": "Russo E., Etges T., Stott C., Wright S., Mohammed A., Robson P. Sativex safety profile is improving over time; Proceedings of the 21st Annual Symposium on the Cannabinoids; St. Charles, IL, USA. 5\u201310 July 2011; Winston-Salem, NC, USA: International Cannabinoid Research Society; 2011."}, {"Citation": "Hartung B., Kauferstein S., Ritz-Timme S., Daldrup T. Sudden unexpected death under acute influence of cannabis. Forensic Sci. Int. 2014;237:e11\u2013e13. doi: 10.1016/j.forsciint.2014.02.001.", "ArticleIdList": ["10.1016/j.forsciint.2014.02.001", "24598271"]}, {"Citation": "Bouchard J.-F., L\u00e9picier P., Lamontagne D. Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart. Life Sci. 2003;72:1859\u20131870. doi: 10.1016/S0024-3205(02)02474-8.", "ArticleIdList": ["10.1016/S0024-3205(02)02474-8", "12586223"]}, {"Citation": "Bonz A., Laser M., K\u00fcllmer S., Kniesch S., Babin-Ebell J., Popp V., Ertl G., Wagner J.A. Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J. Cardiovasc. Pharmacol. 2003;41:657\u2013664. doi: 10.1097/00005344-200304000-00020.", "ArticleIdList": ["10.1097/00005344-200304000-00020", "12658069"]}, {"Citation": "Sidney S. Cardiovascular consequences of marijuana use. J. Clin. Pharmacol. 2002;42:64S\u201370S. doi: 10.1002/j.1552-4604.2002.tb06005.x.", "ArticleIdList": ["10.1002/j.1552-4604.2002.tb06005.x", "12412838"]}, {"Citation": "Wagner J.A., Hu K., Bauersachs J., Karcher J., Wiesler M., Goparaju S.K., Kunos G., Ertl G. Endogenous cannabinoids mediate hypotension after experimental myocardial infarction. J. Am. Coll. Cardiol. 2001;38:2048\u20132054. doi: 10.1016/S0735-1097(01)01671-0.", "ArticleIdList": ["10.1016/S0735-1097(01)01671-0", "11738314"]}, {"Citation": "Mukamal K.J., Maclure M., Muller J.E., Mittleman M.A. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am. Heart J. 2008;155:465\u2013470. doi: 10.1016/j.ahj.2007.10.049.", "ArticleIdList": ["10.1016/j.ahj.2007.10.049", "PMC2276621", "18294478"]}, {"Citation": "Bachs L., M\u00f8rland H. Acute cardiovascular fatalities following cannabis use. Forensic Sci. Int. 2001;124:200\u2013203. doi: 10.1016/S0379-0738(01)00609-0.", "ArticleIdList": ["10.1016/S0379-0738(01)00609-0", "11792512"]}, {"Citation": "Lee J., Sharma N., Kazi F., Youssef I., Myers A., Marmur J.D., Salifu M.O., McFarlane S.I. Cannabis and Myocardial Infarction: Risk Factors and Pathogenetic Insights. SciFed J. Cardiol. 2017;1:1000004.", "ArticleIdList": ["PMC6173198", "30294730"]}, {"Citation": "Charles R., Holt S., Kirkham N. Myocardial infarction and marijuana. Clin. Toxicol. 1979;14:433\u2013438. doi: 10.3109/15563657909010604.", "ArticleIdList": ["10.3109/15563657909010604", "466984"]}, {"Citation": "Desai R., Patel U., Sharma S., Amin P., Bhuva R., Patel M.S., Sharma N., Shah M., Patel S., Savani S., et al. Recreational Marijuana Use and Acute Myocardial Infarction: Insights from Nationwide Inpatient Sample in the United States. Cureus. 2017;9:e1816. doi: 10.7759/cureus.1816.", "ArticleIdList": ["10.7759/cureus.1816", "PMC5752226", "29312837"]}, {"Citation": "Frost L., Mostofsky E., Rosenbloom J.I., Mukamal K.J., Mittleman M.A. Marijuana use and long-term mortality among survivors of acute myocardial infarction. Am. Heart J. 2013;165:170\u2013175. doi: 10.1016/j.ahj.2012.11.007.", "ArticleIdList": ["10.1016/j.ahj.2012.11.007", "PMC3558923", "23351819"]}, {"Citation": "Nogi M., Fergusson D., Chiaco J.M.C. Mid-ventricular variant takotsubo cardiomyopathy associated with cannabinoid hyperemesis syndrome: A case report. Hawai\u2019i J. Med. Public Health. 2014;73:115.", "ArticleIdList": ["PMC3998230", "24765560"]}, {"Citation": "Khalid S., Khalid A., Maroo P. Risk factors and management of Takotsubo cardiomyopathy. Cureus. 2018;10:e2626. doi: 10.7759/cureus.2626.", "ArticleIdList": ["10.7759/cureus.2626", "PMC6044494", "30027018"]}, {"Citation": "Alliu S., Adejumo A., Adegbala O., Namana V., Chetana P., Yevgeniya B., Hecht M., Wolf L., Kamholz S., Hollander G. Association between Cannabis use and TakoTsubo cardiomyopathy (TTC): Analysis from the NIS 2012-2014. Circ. Res. 2017;121:A209."}, {"Citation": "Tournebize J., Gibaja V., Puskarczyk E., Popovic B., Kahn J.-P. Myocarditis associated with cannabis use in a 15-year-old boy: A rare case report. Int. J. Cardiol. 2016;203:243. doi: 10.1016/j.ijcard.2015.10.161.", "ArticleIdList": ["10.1016/j.ijcard.2015.10.161", "26519676"]}, {"Citation": "Leontiadis E., Morshuis M., Arusoglu L., Cobaugh D., Koerfer R., El-Banayosy A. Thoratec left ventricular assist device removal after toxic myocarditis. Ann. Thorac. Surg. 2008;86:1982\u20131985. doi: 10.1016/j.athoracsur.2008.04.092.", "ArticleIdList": ["10.1016/j.athoracsur.2008.04.092", "19022028"]}, {"Citation": "Nappe T.M., Hoyte C.O. Pediatric death due to myocarditis after exposure to cannabis. Clin. Pract. Cases Emerg. Med. 2017;1:166. doi: 10.5811/cpcem.2017.1.33240.", "ArticleIdList": ["10.5811/cpcem.2017.1.33240", "PMC5965161", "29849306"]}, {"Citation": "Rodr\u00edguez-Castro C.E., Alkhateeb H., Elfar A., Saifuddin F., Abbas A., Siddiqui T. Recurrent myopericarditis as a complication of marijuana use. Am. J. Case Rep. 2014;15:60.", "ArticleIdList": ["PMC3921097", "24523950"]}, {"Citation": "Samaan J., Ferrer G.F., Akinyemi B., Junquera P., Oms J., Dumenigo R. Synthetic cannabis overdose and withdrawal in a young adult: A case report, commentary on regulation, and review of the literature. Case Rep. Psychiatry. 2016;2016:3640549. doi: 10.1155/2016/3640549.", "ArticleIdList": ["10.1155/2016/3640549", "PMC5061947", "27777807"]}, {"Citation": "Earleywine M. Understanding Marijuana: A New Look at the Scientific Evidence. Oxford University Press; Oxford, UK: 2002."}, {"Citation": "Matsuda L.A., Bonner T.I., Lolait S.J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 1993;327:535\u2013550. doi: 10.1002/cne.903270406.", "ArticleIdList": ["10.1002/cne.903270406", "8440779"]}, {"Citation": "Misner D.L., Sullivan J.M. Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J. Neurosci. 1999;19:6795\u20136805. doi: 10.1523/JNEUROSCI.19-16-06795.1999.", "ArticleIdList": ["10.1523/JNEUROSCI.19-16-06795.1999", "PMC6782840", "10436037"]}, {"Citation": "Wise L.E., Thorpe A.J., Lichtman A.H. Hippocampal CB 1 receptors mediate the memory impairing effects of \u0394 9-tetrahydrocannabinol. Neuropsychopharmacology. 2009;34:2072\u20132080. doi: 10.1038/npp.2009.31.", "ArticleIdList": ["10.1038/npp.2009.31", "PMC2822461", "19322169"]}, {"Citation": "Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., Hermann H., Tang J., Hofmann C., Zieglg\u00e4nsberger W. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002;418:530\u2013534. doi: 10.1038/nature00839.", "ArticleIdList": ["10.1038/nature00839", "12152079"]}, {"Citation": "Bowman M., Pihl R.O. Cannabis: Psychological effects of chronic heavy use. Psychopharmacologia. 1973;29:159\u2013170. doi: 10.1007/BF00422648.", "ArticleIdList": ["10.1007/BF00422648", "4709840"]}, {"Citation": "Herning R.I., Better W.E., Tate K., Cadet J.L. Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology. 2005;64:488\u2013493. doi: 10.1212/01.WNL.0000150882.69371.DD.", "ArticleIdList": ["10.1212/01.WNL.0000150882.69371.DD", "15699380"]}, {"Citation": "Nahas G.G. Cannabis Physiopathology Epidemiology Detection. CRC Press; Boca Raton, FL, USA: 1992."}, {"Citation": "Ashton C.H. Adverse effects of cannabis and cannabinoids. Br. J. Anaesth. 1999;83:637\u2013649. doi: 10.1093/bja/83.4.637.", "ArticleIdList": ["10.1093/bja/83.4.637", "10673884"]}, {"Citation": "Moore T.M., Stuart G.L., Meehan J.C., Rhatigan D., Hellmuth J.C., Keen S.M. Drug abuse and aggression between intimate partners: A meta-analytic review. Clin. Psychol. Rev. 2008;28:247\u2013274. doi: 10.1016/j.cpr.2007.05.003.", "ArticleIdList": ["10.1016/j.cpr.2007.05.003", "17604891"]}, {"Citation": "Eksborg S., Rajs J. Causes and manners of death among users of heroin, methadone, amphetamine, and cannabis in relation to postmortem chemical tests for illegal drugs. Subst. Use Misuse. 2008;43:1326\u20131339. doi: 10.1080/10826080801922124.", "ArticleIdList": ["10.1080/10826080801922124", "18696371"]}, {"Citation": "De Aquino J.P., Sherif M., Radhakrishnan R., Cahill J.D., Ranganathan M., D\u2019Souza D.C. The psychiatric consequences of cannabinoids. Clin. Ther. 2018;40:1448\u20131456. doi: 10.1016/j.clinthera.2018.03.013.", "ArticleIdList": ["10.1016/j.clinthera.2018.03.013", "29678279"]}, {"Citation": "Reece A.S. Chronic toxicology of cannabis. Clin. Toxicol. 2009;47:517\u2013524. doi: 10.1080/15563650903074507.", "ArticleIdList": ["10.1080/15563650903074507", "19586351"]}, {"Citation": "Wilkinson S.T., Radhakrishnan R., D\u2019Souza D.C. Impact of Cannabis Use on the Development of Psychotic Disorders. Curr. Addict. Rep. 2014;1:115\u2013128. doi: 10.1007/s40429-014-0018-7.", "ArticleIdList": ["10.1007/s40429-014-0018-7", "PMC4352721", "25767748"]}, {"Citation": "Konings M., Henquet C., Maharajh H., Hutchinson G., Van Os J. Early exposure to cannabis and risk for psychosis in young adolescents in Trinidad. Acta Psychiatr. Scand. 2008;118:209\u2013213. doi: 10.1111/j.1600-0447.2008.01202.x.", "ArticleIdList": ["10.1111/j.1600-0447.2008.01202.x", "18452569"]}, {"Citation": "Henquet C., Murray R., Linszen D., van Os J. The environment and schizophrenia: The role of cannabis use. Schizophr. Bull. 2005;31:608\u2013612. doi: 10.1093/schbul/sbi027.", "ArticleIdList": ["10.1093/schbul/sbi027", "15976013"]}, {"Citation": "Degenhardt L., Tennant C., Gilmour S., Schofield D., Nash L., Hall W., McKAY D. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: Findings from a 10-month prospective study. Psychol. Med. 2007;37:927. doi: 10.1017/S0033291707009956.", "ArticleIdList": ["10.1017/S0033291707009956", "17288638"]}, {"Citation": "Coulston C.M., Perdices M., Tennant C.C. The neuropsychological correlates of cannabis use in schizophrenia: Lifetime abuse/dependence, frequency of use, and recency of use. Schizophr. Res. 2007;96:169\u2013184. doi: 10.1016/j.schres.2007.08.006.", "ArticleIdList": ["10.1016/j.schres.2007.08.006", "17826035"]}, {"Citation": "Ksir C., Hart C.L. Cannabis and psychosis: A critical overview of the relationship. Curr. Psychiatry Rep. 2016;18:12. doi: 10.1007/s11920-015-0657-y.", "ArticleIdList": ["10.1007/s11920-015-0657-y", "26781550"]}, {"Citation": "Hamilton I. Cannabis, psychosis and schizophrenia: Unravelling a complex interaction. Addiction. 2017;112:1653\u20131657. doi: 10.1111/add.13826.", "ArticleIdList": ["10.1111/add.13826", "28419656"]}, {"Citation": "Fergusson D.M., Horwood L., Swain-Campbell N. Cannabis dependence and psychotic symptoms in young people. Psychol. Med. 2003;33:15\u201321. doi: 10.1017/S0033291702006402.", "ArticleIdList": ["10.1017/S0033291702006402", "12537032"]}, {"Citation": "Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., Lewis G. Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. Lancet. 2007;370:319\u2013328. doi: 10.1016/S0140-6736(07)61162-3.", "ArticleIdList": ["10.1016/S0140-6736(07)61162-3", "17662880"]}, {"Citation": "Lagerberg T.V., Sundet K., Aminoff S.R., Berg A.O., Ringen P.A., Andreassen O.A., Melle I. Excessive cannabis use is associated with earlier age at onset in bipolar disorder. Eur. Arch. Psychiatry Clin. Neurosci. 2011;261:397\u2013405. doi: 10.1007/s00406-011-0188-4.", "ArticleIdList": ["10.1007/s00406-011-0188-4", "PMC3159738", "21267743"]}, {"Citation": "Lev-Ran S., Le Foll B., McKenzie K., George T.P., Rehm J. Bipolar disorder and co-occurring cannabis use disorders: Characteristics, co-morbidities and clinical correlates. Psychiatry Res. 2013;209:459\u2013465. doi: 10.1016/j.psychres.2012.12.014.", "ArticleIdList": ["10.1016/j.psychres.2012.12.014", "23312479"]}, {"Citation": "van Rossum I., Boomsma M., Tenback D., Reed C., van Os J. Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis. J. Nerv. Ment. Dis. 2009;197:35\u201340. doi: 10.1097/NMD.0b013e31819292a6.", "ArticleIdList": ["10.1097/NMD.0b013e31819292a6", "19155808"]}, {"Citation": "Bovasso G.B. Cannabis abuse as a risk factor for depressive symptoms. Am. J. Psychiatry. 2001;158:2033\u20132037. doi: 10.1176/appi.ajp.158.12.2033.", "ArticleIdList": ["10.1176/appi.ajp.158.12.2033", "11729021"]}, {"Citation": "Degenhardt L., Hall W., Lynskey M. Exploring the association between cannabis use and depression. Addiction. 2003;98:1493\u20131504. doi: 10.1046/j.1360-0443.2003.00437.x.", "ArticleIdList": ["10.1046/j.1360-0443.2003.00437.x", "14616175"]}, {"Citation": "Wu T.-C., Tashkin D.P., Djahed B., Rose J.E. Pulmonary hazards of smoking marijuana as compared with tobacco. N. Engl. J. Med. 1988;318:347\u2013351. doi: 10.1056/NEJM198802113180603.", "ArticleIdList": ["10.1056/NEJM198802113180603", "3340105"]}, {"Citation": "Johnson M.K., Smith R.P., Morrison D., Laszlo G., White R.J. Large lung bullae in marijuana smokers. Thorax. 2000;55:340\u2013342. doi: 10.1136/thorax.55.4.340.", "ArticleIdList": ["10.1136/thorax.55.4.340", "PMC1745720", "10722775"]}, {"Citation": "Huber G.L., First M.W., Grubner O. Marijuana and tobacco smoke gas-phase cytotoxins. Pharmacol. Biochem. Behav. 1991;40:629\u2013636. doi: 10.1016/0091-3057(91)90374-B.", "ArticleIdList": ["10.1016/0091-3057(91)90374-B", "1806950"]}, {"Citation": "Roth M.D., Marques-Magallanes J.A., Yuan M., Sun W., Tashkin D.P., Hankinson O. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and \u03949-tetrahydrocannabinol. Am. J. Respir. Cell Mol. Biol. 2001;24:339\u2013344. doi: 10.1165/ajrcmb.24.3.4252.", "ArticleIdList": ["10.1165/ajrcmb.24.3.4252", "11245634"]}, {"Citation": "MacPhee D. Effects of Marijuana on Cell Nuclei: A Review of the Literature Relating to the Genotoxicity of Cannabis. The Health Effects of Cannabis. Centre for Addiction and Mental Health; Toronto, ON, Canada: 1999. pp. 435\u2013458."}, {"Citation": "Hall W. The respiratory risks of cannabis smoking. Addiction. 1998;93:1461.", "ArticleIdList": ["9926550"]}, {"Citation": "Thompson C., White R. Lung bullae and marijuana. Thorax. 2002;57:563. doi: 10.1136/thorax.57.6.563.", "ArticleIdList": ["10.1136/thorax.57.6.563", "PMC1746350", "12037239"]}, {"Citation": "Fiorelli A., Accardo M., Vicidomini G., Messina G., Laperuta P., Santini M. Does cannabis smoking predispose to lung bulla formation? Asian Cardiovasc. Thorac. Ann. 2014;22:65\u201371. doi: 10.1177/0218492313478954.", "ArticleIdList": ["10.1177/0218492313478954", "24585646"]}, {"Citation": "Reece A. Cannabis as a cause of giant cystic lung disease. QJM Int. J. Med. 2008;101:503. doi: 10.1093/qjmed/hcn040.", "ArticleIdList": ["10.1093/qjmed/hcn040", "18375474"]}, {"Citation": "Ribeiro L.I., Ind P.W. Effect of cannabis smoking on lung function and respiratory symptoms: A structured literature review. NPJ Prim. Care Respir. Med. 2016;26:1\u20138. doi: 10.1038/npjpcrm.2016.71.", "ArticleIdList": ["10.1038/npjpcrm.2016.71", "PMC5072387", "27763599"]}, {"Citation": "Taylor D.R., Hall W. Respiratory health effects of cannabis: Position statement of the Thoracic Society of Australia and New Zealand. Intern. Med. J. 2003;33:310\u2013313. doi: 10.1046/j.1445-5994.2003.00401.x.", "ArticleIdList": ["10.1046/j.1445-5994.2003.00401.x", "12823677"]}, {"Citation": "Mehra R., Moore B.A., Crothers K., Tetrault J., Fiellin D.A. The association between marijuana smoking and lung cancer: A systematic review. Arch. Intern. Med. 2006;166:1359\u20131367. doi: 10.1001/archinte.166.13.1359.", "ArticleIdList": ["10.1001/archinte.166.13.1359", "16832000"]}, {"Citation": "Berthiller J., Straif K., Boniol M., Voirin N., Benha\u00efm-Luzon V., Ayoub W.B., Dari I., Laouamri S., Hamdi-Cherif M., Bartal M. Cannabis smoking and risk of lung cancer in men: A pooled analysis of three studies in Maghreb. J. Thorac. Oncol. 2008;3:1398\u20131403. doi: 10.1097/JTO.0b013e31818ddcde.", "ArticleIdList": ["10.1097/JTO.0b013e31818ddcde", "19057263"]}, {"Citation": "Callaghan R.C., Allebeck P., Sidorchuk A. Marijuana use and risk of lung cancer: A 40-year cohort study. Cancer Causes Control. 2013;24:1811\u20131820. doi: 10.1007/s10552-013-0259-0.", "ArticleIdList": ["10.1007/s10552-013-0259-0", "23846283"]}, {"Citation": "Melamede R. Cannabis and tobacco smoke are not equally carcinogenic. Harm Reduct. J. 2005;2:1\u20134.", "ArticleIdList": ["PMC1277837", "16232311"]}, {"Citation": "Hart S., Fischer O.M., Ullrich A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor \u03b1-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 2004;64:1943\u20131950. doi: 10.1158/0008-5472.CAN-03-3720.", "ArticleIdList": ["10.1158/0008-5472.CAN-03-3720", "15026328"]}, {"Citation": "Tetrault J.M., Crothers K., Moore B.A., Mehra R., Concato J., Fiellin D.A. Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review. Arch. Intern. Med. 2007;167:221\u2013228. doi: 10.1001/archinte.167.3.221.", "ArticleIdList": ["10.1001/archinte.167.3.221", "PMC2720277", "17296876"]}, {"Citation": "Ghasemiesfe M., Ravi D., Vali M., Korenstein D., Arjomandi M., Frank J., Austin P.C., Keyhani S. Marijuana use, respiratory symptoms, and pulmonary function: A systematic review and meta-analysis. Ann. Intern. Med. 2018;169:106\u2013115. doi: 10.7326/M18-0522.", "ArticleIdList": ["10.7326/M18-0522", "PMC6231497", "29971337"]}, {"Citation": "Winhusen T., Theobald J., Kaelber D.C., Lewis D. Regular cannabis use, with and without tobacco co-use, is associated with respiratory disease. Drug Alcohol Depend. 2019;204:107557. doi: 10.1016/j.drugalcdep.2019.107557.", "ArticleIdList": ["10.1016/j.drugalcdep.2019.107557", "PMC6878136", "31557578"]}, {"Citation": "Maykut M.O. Health consequences of acute and chronic marihuana use. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 1985;9:209\u2013238. doi: 10.1016/0278-5846(85)90085-5.", "ArticleIdList": ["10.1016/0278-5846(85)90085-5", "3898227"]}, {"Citation": "Baldwin G.C., Tashkin D.P., Buckley D.M., Park A.N., Dubinett S.M., Roth M.D. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am. J. Respir. Crit. Care Med. 1997;156:1606\u20131613. doi: 10.1164/ajrccm.156.5.9704146.", "ArticleIdList": ["10.1164/ajrccm.156.5.9704146", "9372683"]}, {"Citation": "Russo E.B. Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential. Routledge; Abingdon, UK: 2013."}, {"Citation": "Dalterio S., Bartke A., Mayfield D. Effects of \u03949-tetrahydrocannabinol on testosterone production in vitro: Influence of Ca++, Mg++ or glucose. Life Sci. 1985;37:1425\u20131433. doi: 10.1016/0024-3205(85)90082-7.", "ArticleIdList": ["10.1016/0024-3205(85)90082-7", "2995745"]}, {"Citation": "Rettori V., Wenger T., Snyder G., Dalterio S., McCann S.M. Hypothalamic action of delta-9-tetrahydrocannabinol to inhibit the release of prolactin and growth hormone in the rat. Neuroendocrinology. 1988;47:498\u2013503. doi: 10.1159/000124961.", "ArticleIdList": ["10.1159/000124961", "2840598"]}, {"Citation": "Payne K.S., Mazur D.J., Hotaling J.M., Pastuszak A.W. Cannabis and male fertility: A systematic review. J. Urol. 2019;202:674\u2013681. doi: 10.1097/JU.0000000000000248.", "ArticleIdList": ["10.1097/JU.0000000000000248", "PMC7385722", "30916627"]}, {"Citation": "Agirregoitia E., Carracedo A., Subir\u00e1n N., Valdivia A., Agirregoitia N., Peralta L., Velasco G., Irazusta J. The CB2 cannabinoid receptor regulates human sperm cell motility. Fertil. Steril. 2010;93:1378\u20131387. doi: 10.1016/j.fertnstert.2009.01.153.", "ArticleIdList": ["10.1016/j.fertnstert.2009.01.153", "19328464"]}, {"Citation": "Hembree W.C., Nahas G.G., Zeidenberg P., Huang H.F. Marihuana and medicine. Springer; Berlin/Heidelberg, Germany: 1999. Changes in human spermatozoa associated with high-dose marihuana smoking; pp. 367\u2013378."}, {"Citation": "du Plessis S.S., Agarwal A., Syriac A. Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility. J. Assist. Reprod. Genet. 2015;32:1575\u20131588. doi: 10.1007/s10815-015-0553-8.", "ArticleIdList": ["10.1007/s10815-015-0553-8", "PMC4651943", "26277482"]}, {"Citation": "Harclerode J. Endocrine effects of marijuana in the male: Preclinical studies. NIDA Res. Monogr. 1984;44:46\u201364.", "ArticleIdList": ["6090909"]}, {"Citation": "Hollister L.E. Health aspects of cannabis. Pharmacol. Rev. 1986;38:1\u201320. doi: 10.1016/0378-8741(87)90030-4.", "ArticleIdList": ["10.1016/0378-8741(87)90030-4", "3520605"]}, {"Citation": "Ghosh S. Natural Products-From Bioactive Molecules to Human Health. IntechOpen Limited; London, UK: Rijeka, Croatia: 2020. Cannabis Effect on Female Reproductive Health.", "ArticleIdList": ["10.5772/intechopen.91620"]}, {"Citation": "Mendelson J.H., Mello N., Ellingboe J. Acute effects of marihuana smoking on prolactin levels in human females. J. Pharmacol. Exp. Ther. 1985;232:220\u2013222.", "ArticleIdList": ["3965692"]}, {"Citation": "Block R.I., Farinpour R., Schlechte J.A. Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend. 1991;28:121\u2013128. doi: 10.1016/0376-8716(91)90068-A.", "ArticleIdList": ["10.1016/0376-8716(91)90068-A", "1935564"]}, {"Citation": "Corsi D.J., Murphy M., Cook J. The Effects of Cannabis on Female Reproductive Health Across the Life Course. Cannabis Cannabinoid Res. 2020 doi: 10.1089/can.2020.0065.", "ArticleIdList": ["10.1089/can.2020.0065", "PMC8380785", "33998877"]}, {"Citation": "Gold M. Drugs of Abuse: A Comprehensive Series for Clinicians. Volume 1 Plenum Press; London, UK: 1989. Marijuana."}, {"Citation": "Sims E.D., Anvari S., Lee Y., Samaan Z., Banfield L., Thabane L., Samaan M.C. The effect of cannabis exposure on pubertal outcomes: A systematic review. Adolesc. Health Med. Ther. 2018;9:137\u2013147. doi: 10.2147/AHMT.S175864.", "ArticleIdList": ["10.2147/AHMT.S175864", "PMC6181473", "30349416"]}, {"Citation": "Copeland K.C., Underwood L.E., Van Wyk J.J. Marihuana smoking and pubertal arrest. J. Pediatr. 1980;96:1079\u20131080. doi: 10.1016/S0022-3476(80)80648-2.", "ArticleIdList": ["10.1016/S0022-3476(80)80648-2", "7373474"]}, {"Citation": "Volkow N.D., Han B., Compton W.M., McCance-Katz E.F. Self-reported medical and nonmedical cannabis use among pregnant women in the United States. JAMA. 2019;322:167\u2013169. doi: 10.1001/jama.2019.7982.", "ArticleIdList": ["10.1001/jama.2019.7982", "PMC6582258", "31211824"]}, {"Citation": "Roncero C., Valriberas-Herrero I., Mezzatesta-Gava M., Villegas J.L., Aguilar L., Grau-L\u00f3pez L. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. Reprod. Health. 2020;17:1\u20139. doi: 10.1186/s12978-020-0880-9.", "ArticleIdList": ["10.1186/s12978-020-0880-9", "PMC7027300", "32066469"]}, {"Citation": "Lozano J., Garc\u00eda-Algar O., Marchei E., Vall O., Monleon T., Giovannandrea R.D., Pichini S. Prevalence of gestational exposure to cannabis in a Mediterranean city by meconium analysis. Acta Paediatr. 2007;96:1734\u20131737. doi: 10.1111/j.1651-2227.2007.00535.x.", "ArticleIdList": ["10.1111/j.1651-2227.2007.00535.x", "17953730"]}, {"Citation": "El Marroun H., Tiemeier H., Jaddoe V.W., Hofman A., Mackenbach J.P., Steegers E.A., Verhulst F.C., van den Brink W., Huizink A.C. Demographic, emotional and social determinants of cannabis use in early pregnancy: The Generation R study. Drug Alcohol Depend. 2008;98:218\u2013226. doi: 10.1016/j.drugalcdep.2008.05.010.", "ArticleIdList": ["10.1016/j.drugalcdep.2008.05.010", "18606505"]}, {"Citation": "Jaques S.C., Kingsbury A., Henshcke P., Chomchai C., Clews S., Falconer J., Abdel-Latif M.E., Feller J.M., Oei J.L. Cannabis, the pregnant woman and her child: Weeding out the myths. J. Perinatol. Off. J. Calif. Perinat. Assoc. 2014;34:417\u2013424. doi: 10.1038/jp.2013.180.", "ArticleIdList": ["10.1038/jp.2013.180", "24457255"]}, {"Citation": "Bailey J., Cunny H., Paule M., Slikker Jr W. Fetal disposition of \u03949-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. Toxicol. Appl. Pharmacol. 1987;90:315\u2013321. doi: 10.1016/0041-008X(87)90338-3.", "ArticleIdList": ["10.1016/0041-008X(87)90338-3", "2820086"]}, {"Citation": "G\u00f3mez M., Hern\u00e1ndez M., Johansson B., de Miguel R., Ramos J.A., Fern\u00e1ndez-Ruiz J. Prenatal cannabinoid exposure and gene expression for neural adhesion molecule L1 in the fetal rat brain. Dev. Brain Res. 2003;147:201\u2013207. doi: 10.1016/j.devbrainres.2003.10.016.", "ArticleIdList": ["10.1016/j.devbrainres.2003.10.016", "15068010"]}, {"Citation": "Smith A.M., Mioduszewski O., Hatchard T., Byron-Alhassan A., Fall C., Fried P.A. Prenatal marijuana exposure impacts executive functioning into young adulthood: An fMRI study. Neurotoxicol. Teratol. 2016;58:53\u201359. doi: 10.1016/j.ntt.2016.05.010.", "ArticleIdList": ["10.1016/j.ntt.2016.05.010", "27263090"]}, {"Citation": "Smith A.M., Fried P.A., Hogan M.J., Cameron I. Effects of prenatal marijuana on visuospatial working memory: An fMRI study in young adults. Neurotoxicol. Teratol. 2006;28:286\u2013295. doi: 10.1016/j.ntt.2005.12.008.", "ArticleIdList": ["10.1016/j.ntt.2005.12.008", "16473495"]}, {"Citation": "Fried P.A., Watkinson B., Gray R. Differential effects on cognitive functioning in 13-to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol. Teratol. 2003;25:427\u2013436. doi: 10.1016/S0892-0362(03)00029-1.", "ArticleIdList": ["10.1016/S0892-0362(03)00029-1", "12798960"]}, {"Citation": "Smith A.M., Longo C.A., Fried P.A., Hogan M.J., Cameron I. Effects of marijuana on visuospatial working memory: An fMRI study in young adults. Psychopharmacology. 2010;210:429\u2013438. doi: 10.1007/s00213-010-1841-8.", "ArticleIdList": ["10.1007/s00213-010-1841-8", "20401748"]}, {"Citation": "Goldschmidt L., Richardson G.A., Willford J., Day N.L. Prenatal marijuana exposure and intelligence test performance at age 6. J. Am. Acad. Child Adolesc. Psychiatry. 2008;47:254\u2013263. doi: 10.1097/CHI.0b013e318160b3f0.", "ArticleIdList": ["10.1097/CHI.0b013e318160b3f0", "18216735"]}, {"Citation": "Sharapova S.R., Phillips E., Sirocco K., Kaminski J.W., Leeb R.T., Rolle I. Effects of prenatal marijuana exposure on neuropsychological outcomes in children aged 1\u201311 years: A systematic review. Paediatr. Perinat. Epidemiol. 2018;32:512\u2013532. doi: 10.1111/ppe.12505.", "ArticleIdList": ["10.1111/ppe.12505", "PMC6261687", "30335203"]}, {"Citation": "de Moraes Barros M.C., Guinsburg R., de Ara\u00fajo Peres C., Mitsuhiro S., Chalem E., Laranjeira R.R. Exposure to marijuana during pregnancy alters neurobehavior in the early neonatal period. J. Pediatrics. 2006;149:781\u2013787. doi: 10.1016/j.jpeds.2006.08.046.", "ArticleIdList": ["10.1016/j.jpeds.2006.08.046", "17137892"]}, {"Citation": "Fried P.A., Makin J. Neonatal behavioural correlates of prenatal exposure to marihuana, cigarettes and alcohol in a low risk population. Neurotoxicol. Teratol. 1987;9:1\u20137. doi: 10.1016/0892-0362(87)90062-6.", "ArticleIdList": ["10.1016/0892-0362(87)90062-6", "3627073"]}, {"Citation": "Lester B.M., Dreher M. Effects of marijuana use during pregnancy on newborn cry. Child Dev. 1989;60:765\u2013771. doi: 10.2307/1131016.", "ArticleIdList": ["10.2307/1131016", "2758874"]}, {"Citation": "Forrester M.B., Merz R.D. Risk of selected birth defects with prenatal illicit drug use, Hawaii, 1986\u20132002. J. Toxicol. Environ. Health Part A. 2006;70:7\u201318. doi: 10.1080/15287390600748799.", "ArticleIdList": ["10.1080/15287390600748799", "17162495"]}, {"Citation": "Robison L.L., Buckley J.D., Daigle A.E., Wells R., Benjamin D., Arthur D.C., Hammond G.D. Maternal drug use and risk of childhood nonlymphoblastic leukemia among offspring. An epidemiologic investigation implicating marijuana (a report from the Childrens Cancer Study Group) Cancer. 1989;63:1904\u20131911. doi: 10.1002/1097-0142(19890515)63:10<1904::AID-CNCR2820631006>3.0.CO;2-W.", "ArticleIdList": ["10.1002/1097-0142(19890515)63:10<1904::AID-CNCR2820631006>3.0.CO;2-W", "2649219"]}, {"Citation": "Huizink A. Prenatal cannabis exposure and infant outcomes: Overview of studies. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2014;52:45\u201352. doi: 10.1016/j.pnpbp.2013.09.014.", "ArticleIdList": ["10.1016/j.pnpbp.2013.09.014", "24075896"]}, {"Citation": "Navarro M., De Fonseca F.R., Hernandez M., Ramos J., Fernandez-Ruiz J. Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids. Pharmacol. Biochem. Behav. 1994;47:47\u201358. doi: 10.1016/0091-3057(94)90110-4.", "ArticleIdList": ["10.1016/0091-3057(94)90110-4", "7906890"]}, {"Citation": "Antonelli T., Tomasini M.C., Tattoli M., Cassano T., Tanganelli S., Finetti S., Mazzoni E., Trabace L., Steardo L., Cuomo V. Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb. Cortex. 2005;15:2013\u20132020. doi: 10.1093/cercor/bhi076.", "ArticleIdList": ["10.1093/cercor/bhi076", "15788701"]}, {"Citation": "Campolongo P., Trezza V., Ratano P., Palmery M., Cuomo V. Developmental consequences of perinatal cannabis exposure: Behavioral and neuroendocrine effects in adult rodents. Psychopharmacology. 2011;214:5\u201315. doi: 10.1007/s00213-010-1892-x.", "ArticleIdList": ["10.1007/s00213-010-1892-x", "PMC3045519", "20556598"]}, {"Citation": "DiNieri J.A., Wang X., Szutorisz H., Spano S.M., Kaur J., Casaccia P., Dow-Edwards D., Hurd Y.L. Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol. Psychiatry. 2011;70:763\u2013769. doi: 10.1016/j.biopsych.2011.06.027.", "ArticleIdList": ["10.1016/j.biopsych.2011.06.027", "PMC3186868", "21820648"]}, {"Citation": "Scheyer A.F., Borsoi M., Wager-Miller J., Pelissier-Alicot A.-L., Murphy M.N., Mackie K., Manzoni O.J. Cannabinoid exposure via lactation in rats disrupts perinatal programming of the gamma-aminobutyric acid trajectory and select early-life behaviors. Biol. Psychiatry. 2020;87:666\u2013677. doi: 10.1016/j.biopsych.2019.08.023.", "ArticleIdList": ["10.1016/j.biopsych.2019.08.023", "PMC7056509", "31653479"]}, {"Citation": "Bonnin A., De Miguel R., Hernandez M., Ramos J., Fernandez-Ruiz J. The prenatal exposure to \u03949-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development. Life Sci. 1995;56:2177\u20132184. doi: 10.1016/0024-3205(95)00205-K.", "ArticleIdList": ["10.1016/0024-3205(95)00205-K", "7776847"]}, {"Citation": "Bonnin A., de Miguel R., Castro J.G., Ramos J.A., Fernandez-Ruiz J.J. Effects of perinatal exposure to \u0394 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain. J. Mol. Neurosci. 1996;7:291\u2013308. doi: 10.1007/BF02737066.", "ArticleIdList": ["10.1007/BF02737066", "8968950"]}, {"Citation": "Morales P., Hurst D.P., Reggio P.H. Phytocannabinoids. Springer; Berlin/Heidelberg, Germany: 2017. Molecular targets of the phytocannabinoids: A complex picture; pp. 103\u2013131.", "ArticleIdList": ["PMC5345356", "28120232"]}, {"Citation": "Weimar H.V., Wright H.R., Warrick C.R., Brown A.M., Lugo J.M., Freels T.G., McLaughlin R.J. Maternal cannabis vapor exposure causes long-term alterations in emotional reactivity, social behavior, and behavioral flexibility in offspring. bioRxiv. :2020. doi: 10.1101/2020.03.12.989210.", "ArticleIdList": ["10.1101/2020.03.12.989210", "32860776"]}, {"Citation": "Panlilio L.V., Goldberg S.R., Justinova Z. Cannabinoid abuse and addiction: Clinical and preclinical findings. Clin. Pharmacol. Ther. 2015;97:616\u2013627. doi: 10.1002/cpt.118.", "ArticleIdList": ["10.1002/cpt.118", "PMC4446186", "25788435"]}, {"Citation": "Patel J., Marwaha R. Cannabis Use Disorder. StatPearls; Treasure Island, FL, USA: 2020."}, {"Citation": "Budney A.J., Roffman R., Stephens R.S., Walker D. Marijuana dependence and its treatment. Addict. Sci. Clin. Pract. 2007;4:4\u201316. doi: 10.1151/ASCP07414.", "ArticleIdList": ["10.1151/ASCP07414", "PMC2797098", "18292704"]}, {"Citation": "Ramesh D., Schlosburg J.E., Wiebelhaus J.M., Lichtman A.H. Marijuana dependence: Not just smoke and mirrors. ILAR J. 2011;52:295\u2013308. doi: 10.1093/ilar.52.3.295.", "ArticleIdList": ["10.1093/ilar.52.3.295", "PMC3606907", "23382144"]}, {"Citation": "Bonnet U., Preuss U.W. The cannabis withdrawal syndrome: Current insights. Subst. Abus. Rehabil. 2017;8:9\u201337. doi: 10.2147/SAR.S109576.", "ArticleIdList": ["10.2147/SAR.S109576", "PMC5414724", "28490916"]}, {"Citation": "Freeman T.P., Hindocha C., Baio G., Shaban N.D.C., Thomas E.M., Astbury D., Freeman A.M., Lees R., Craft S., Morrison P.D., et al. Cannabidiol for the treatment of cannabis use disorder: A phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial. Lancet Psychiatry. 2020;7:865\u2013874. doi: 10.1016/S2215-0366(20)30290-X.", "ArticleIdList": ["10.1016/S2215-0366(20)30290-X", "PMC7116091", "32735782"]}, {"Citation": "Gilbert D.G., Rabinovich N.E., McDaniel J.T. Nicotine patch for cannabis withdrawal symptom relief: A randomized controlled trial. Psychopharmacology. 2020;237:1507\u20131519. doi: 10.1007/s00213-020-05476-1.", "ArticleIdList": ["10.1007/s00213-020-05476-1", "32034447"]}, {"Citation": "Sherman B.J., Caruso M.A., McRae-Clark A.L. Exogenous progesterone for cannabis withdrawal in women: Feasibility trial of a novel multimodal methodology. Pharmacol. Biochem. Behav. 2019;179:22\u201326. doi: 10.1016/j.pbb.2019.01.008.", "ArticleIdList": ["10.1016/j.pbb.2019.01.008", "PMC6435393", "30711528"]}, {"Citation": "Allsop D.J., Copeland J., Lintzeris N., Dunlop A.J., Montebello M., Sadler C., Rivas G.R., Holland R.M., Muhleisen P., Norberg M.M., et al. Nabiximols as an agonist replacement therapy during cannabis withdrawal: A randomized clinical trial. JAMA Psychiatry. 2014;71:281\u2013291. doi: 10.1001/jamapsychiatry.2013.3947.", "ArticleIdList": ["10.1001/jamapsychiatry.2013.3947", "24430917"]}, {"Citation": "Haney M., Hart C.L., Vosburg S.K., Comer S.D., Reed S.C., Foltin R.W. Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse. Psychopharmacology. 2008;197:157\u2013168. doi: 10.1007/s00213-007-1020-8.", "ArticleIdList": ["10.1007/s00213-007-1020-8", "PMC3372576", "18161012"]}, {"Citation": "Walther L., Gantner A., Heinz A., Majic T. Evidence-based Treatment Options in Cannabis Dependency. Dtsch. Arztebl. Int. 2016;113:653\u2013659. doi: 10.3238/arztebl.2016.0653.", "ArticleIdList": ["10.3238/arztebl.2016.0653", "PMC5098026", "27776623"]}, {"Citation": "Antoniou T., Bodkin J., Ho J.M. Drug interactions with cannabinoids. CMAJ. 2020;192:E206. doi: 10.1503/cmaj.191097.", "ArticleIdList": ["10.1503/cmaj.191097", "PMC7055953", "32122975"]}, {"Citation": "Brown J.D., Winterstein A.G. Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. J. Clin. Med. 2019;8:989. doi: 10.3390/jcm8070989.", "ArticleIdList": ["10.3390/jcm8070989", "PMC6678684", "31288397"]}, {"Citation": "Stott C., White L., Wright S., Wilbraham D., Guy G. A Phase I, open-label, randomized, crossover study in three parallel groups to evaluate the effect of Rifampicin, Ketoconazole, and Omeprazole on the pharmacokinetics of THC/CBD oromucosal spray in healthy volunteers. SpringerPlus. 2013;2:236. doi: 10.1186/2193-1801-2-236.", "ArticleIdList": ["10.1186/2193-1801-2-236", "PMC3671111", "23750331"]}, {"Citation": "Cox E.J., Maharao N., Patilea-Vrana G., Unadkat J.D., Rettie A.E., McCune J.S., Paine M.F. A marijuana-drug interaction primer: Precipitants, pharmacology, and pharmacokinetics. Pharmacol. Ther. 2019;201:25\u201338. doi: 10.1016/j.pharmthera.2019.05.001.", "ArticleIdList": ["10.1016/j.pharmthera.2019.05.001", "PMC6708768", "31071346"]}, {"Citation": "Geffrey A.L., Pollack S.F., Bruno P.L., Thiele E.A. Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy. Epilepsia. 2015;56:1246\u20131251. doi: 10.1111/epi.13060.", "ArticleIdList": ["10.1111/epi.13060", "26114620"]}, {"Citation": "Zvonarev V., Fatuki T.A., Tregubenko P. The Public Health Concerns of Marijuana Legalization: An Overview of Current Trends. Cureus. 2019;11:e5806. doi: 10.7759/cureus.5806.", "ArticleIdList": ["10.7759/cureus.5806", "PMC6837267", "31723545"]}, {"Citation": "Turner A.R., Agrawal S. StatPearls. StatPearls Publishing; Treasure Island, FL, USA: 2020. Marijuana."}, {"Citation": "Mead A. Legal and Regulatory Issues Governing Cannabis and Cannabis-Derived Products in the United States. Front. Plant Sci. 2019;10:697. doi: 10.3389/fpls.2019.00697.", "ArticleIdList": ["10.3389/fpls.2019.00697", "PMC6590107", "31263468"]}, {"Citation": "European Monitoring Centre for Drugs and Drug Additions . Medical Use of Cannabis and Cannabinoids: Questions and Answers for Policymaking. EMCDDA; Lisbon, Portugal: 2018. p. 44."}, {"Citation": "Bahji A., Stephenson C. International Perspectives on the Implications of Cannabis Legalization: A Systematic Review & Thematic Analysis. Int. J. Environ. Res. Public Health. 2019;16:3095. doi: 10.3390/ijerph16173095.", "ArticleIdList": ["10.3390/ijerph16173095", "PMC6747067", "31454942"]}, {"Citation": "Hall W., Lynskey M. Assessing the public health impacts of legalizing recreational cannabis use: The US experience. World Psychiatry Offi. J. World Psychiatr. Assoc. 2020;19:179\u2013186. doi: 10.1002/wps.20735.", "ArticleIdList": ["10.1002/wps.20735", "PMC7215066", "32394566"]}, {"Citation": "Leyton M. Cannabis legalization: Did we make a mistake? Update 2019. J. Psychiatry Neurosci. JPN. 2019;44:291\u2013293. doi: 10.1503/jpn.190136.", "ArticleIdList": ["10.1503/jpn.190136", "PMC6710088", "31452361"]}, {"Citation": "Di Forti M. To legalize or not to legalize cannabis, that is the question! World Psychiatry Offi. J. World Psychiatr. Assoc. 2020;19:188\u2013189. doi: 10.1002/wps.20737.", "ArticleIdList": ["10.1002/wps.20737", "PMC7214953", "32394550"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "31"}, {"Year": "2021", "Month": "1", "Day": "31"}, {"Year": "2021", "Month": "2", "Day": "1"}, {"Year": "2021", "Month": "2", "Day": "10", "Hour": "1", "Minute": "2"}, {"Year": "2021", "Month": "2", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "2", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["33562446", "PMC7915118", "10.3390/toxins13020117", "toxins13020117"]}}], "PubmedBookArticle": []}